Literature DB >> 33593373

YKL-40 as a new promising prognostic marker of severity in COVID infection.

Etienne Cavalier1, Julien Guiot2, Lauranne Schoneveld3, Aurélie Ladang3, Monique Henket2, Anne-Noëlle Frix2.   

Abstract

Entities:  

Keywords:  COVID-19; Chitinase 3-like 1; Interstitial lung disease; SARS-CoV-2; YKL-40

Year:  2021        PMID： 33593373     DOI： 10.1186/s13054-020-03383-7

Source DB:  PubMed          Journal:  Crit Care        ISSN： 1364-8535            Impact factor:   9.097


× No keyword cloud information.
  4 in total

1.  West Nile Virus Neuroinfection in Humans: Peripheral Biomarkers of Neuroinflammation and Neuronal Damage.

Authors:  Orianne Constant; Jonathan Barthelemy; Anna Nagy; Sara Salinas; Yannick Simonin
Journal:  Viruses       Date:  2022-04-04       Impact factor: 5.818

2.  Chitinase-3-like protein-1 at hospital admission predicts COVID-19 outcome: a prospective cohort study.

Authors:  Rebecca De Lorenzo; Clara Sciorati; Nicola I Lorè; Annalisa Capobianco; Cristina Tresoldi; Daniela M Cirillo; Fabio Ciceri; Patrizia Rovere-Querini; Angelo A Manfredi
Journal:  Sci Rep       Date:  2022-05-09       Impact factor: 4.996

3.  Serum YKL-40 Levels Predict Endotypes and Associate with Postoperative Recurrence in Patients with Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Sihui Wen; Shenghao Cheng; Shaobing Xie; Hua Zhang; Zhihai Xie; Weihong Jiang
Journal:  J Asthma Allergy       Date:  2021-10-29

4.  Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study.

Authors:  Gilles Darcis; Antoine Bouquegneau; Nathalie Maes; Marie Thys; Monique Henket; Florence Labye; Anne-Françoise Rousseau; Perrine Canivet; Colin Desir; Doriane Calmes; Raphael Schils; Sophie De Worm; Philippe Léonard; Paul Meunier; Michel Moutschen; Renaud Louis; Julien Guiot
Journal:  Int J Infect Dis       Date:  2021-07-14       Impact factor: 3.623
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.